{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:27Z","timestamp":1707523947349},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,22]]},"DOI":"10.7759\/cureus.43927","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T15:24:08Z","timestamp":1692717848000},"source":"Crossref","is-referenced-by-count":0,"title":["Soft Tissue Mass Extramedullary Plasmacytoma Following Radiation Therapy for Solitary Bone Plasmacytoma"],"prefix":"10.7759","author":[{"given":"Jong H","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray D","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Chung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh-Triet","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Elete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq370","article-title":"Multiple myeloma","volume":"21 Suppl 7","author":"Dimopoulos MA","year":"2010","unstructured":"Dimopoulos MA, Terpos E. Multiple myeloma. Ann Oncol. 2010, 21 Suppl 7:vii143-50. 10.1093\/annonc\/mdq370","journal-title":"Ann Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4816","article-title":"Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts\u2014a follow-up","volume":"11","author":"Holler A","year":"2022","unstructured":"Holler A, Cicha I, Eckstein M, et al.. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts\u2014a follow-up. Cancer Med. 2022, 11:4743-55. 10.1002\/cam4.4816","journal-title":"Cancer Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2013.1712","article-title":"Extramedullary plasmacytoma of the nasopharynx: a case report and review of the literature","volume":"7","author":"Chang YL","year":"2014","unstructured":"Chang YL, Chen PY, Hung SH. Extramedullary plasmacytoma of the nasopharynx: a case report and review of the literature. Oncol Lett. 2014, 7:458-60. 10.3892\/ol.2013.1712","journal-title":"Oncol Lett"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma","volume":"17","author":"Kumar S","year":"2017","unstructured":"Kumar S, Paiva B, Anderson KC, et al.. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2017, 17:328-46. 10.1016\/S1470-2045(16)30206-6","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06599.x","article-title":"Solitary plasmacytoma and multiple myeloma: adhesion molecule and chemokine receptor expression patterns","volume":"137","author":"Hughes M","year":"2007","unstructured":"Hughes M, Doig A, Soutar R. Solitary plasmacytoma and multiple myeloma: adhesion molecule and chemokine receptor expression patterns. Br J Haematol. 2007, 137:486-7. 10.1111\/j.1365-2141.2007.06599.x","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar SV","year":"2014","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A, et al.. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014, 15:538-48. 10.1016\/s1470-2045(14)70442-5","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"Kyle R","year":"2003","unstructured":"Kyle R. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003, 121:749-57. 10.1046\/j.1365-2141.2003.04355.x","journal-title":"Br J Haematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.4.587","article-title":"Curability of solitary bone plasmacytoma","volume":"10","author":"Dimopoulos MA","year":"1992","unstructured":"Dimopoulos MA, Goldstein J, Fuller L, Delasalle K, Alexanian R. Curability of solitary bone plasmacytoma. J Clin Oncol. 1992, 10:587-90. 10.1200\/JCO.1992.10.4.587","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0099-8","article-title":"Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset","volume":"32","author":"Goyal G","year":"2018","unstructured":"Goyal G, Bartley AC, Funni S, et al.. Treatment approaches and outcomes in plasmacytomas: analysis using a national dataset. Leukemia. 2018, 32:1414-20. 10.1038\/s41375-018-0099-8","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(89)90008-4","article-title":"Solitary plasmacytoma of bone: Mayo Clinic experience","volume":"16","author":"Frassica DA","year":"1989","unstructured":"Frassica DA, Frassica FJ, Schray MF, Sim FH, Kyle RA. Solitary plasmacytoma of bone: Mayo Clinic experience. Int J Radiat Oncol Biol Phys. 1989, 16:43-8. 10.1016\/0360-3016(89)90008-4","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-565135","article-title":"Treatment recommendations for patients with Waldenstr\u00f6m macroglobulinemia (WM) and related disorders: IWWM-7 consensus","volume":"124","author":"Dimopoulos MA","year":"2014","unstructured":"Dimopoulos MA, Kastritis E, Owen RG, et al.. Treatment recommendations for patients with Waldenstr\u00f6m macroglobulinemia (WM) and related disorders: IWWM-7 consensus. Blood. 2014, 124:1404-11. 10.1182\/blood-2014-03-565135","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0360-3016(00)01572-8","article-title":"Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome","volume":"50","author":"Tsang RW","year":"2001","unstructured":"Tsang RW, Gospodarowicz MK, Pintilie M, et al.. Solitary plasmacytoma treated with radiotherapy: impact of tumor size on outcome. Int J Radiat Oncol Biol Phys. 2001, 50:113-20. 10.1016\/S0360-3016(00)01572-8","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-0298-1","article-title":"Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis","volume":"10","author":"Zhang S","year":"2020","unstructured":"Zhang S, Kulkarni AA, Xu B, et al.. Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis. Blood Cancer J. 2020, 10:33. 10.1038\/s41408-020-0298-1","journal-title":"Blood Cancer J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.508","article-title":"Management of multiple myeloma in the relapsed\/refractory patient","volume":"2017","author":"Sonneveld P","year":"2017","unstructured":"Sonneveld P. Management of multiple myeloma in the relapsed\/refractory patient. Hematology Am Soc Hematol Educ Program. 2017, 2017:508-17. 10.1182\/asheducation-2017.1.508","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/168274-soft-tissue-mass-extramedullary-plasmacytoma-following-radiation-therapy-for-solitary-bone-plasmacytoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:59Z","timestamp":1707508439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/168274-soft-tissue-mass-extramedullary-plasmacytoma-following-radiation-therapy-for-solitary-bone-plasmacytoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,22]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.43927","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,22]]}}}